Proteomics International: Aaron Brinkworth, Roger Moore, James Williams, Neville Gardiner

Proteomics International of Perth, Australia, has appointed Aaron Brinkworth as an independent, non-executive director, effective Nov. 8. He succeeds Roger Moore, who is retiring. Brinkworth is a former biopharmaceutical executive who held various senior commercial, patient access, and strategic licensing roles at Gilead Sciences. The firm also said that non-executive director James Williams will become chair of the board as of Nov. 8, succeeding Neville Gardiner, who will remain a non-executive director.